Cardiology Update

APRIL 25, 2024

RELIEVE-HF investigators evaluated the efficacy and safety of the V-wave interatrial shunt system in patients with heart failure. The primary endpoint was a composite of all-cause mortality, left ventricular assist device (LVAD)/heart transplantation, HF hospitalizations, worsening HF, and KCCQ score changes. Atlanta, GA.

Heart Failure 98

Heart Failure Heart Transplant Transplant Research 98

Circulation: Cardiovascular Imaging

APRIL 2, 2024

BACKGROUND:In heart transplant recipients, right ventricular (RV) dysfunction may occur for a variety of reasons. Whether RV dysfunction in the stable phase after heart transplantation is associated with long-term adverse outcomes is unknown. years after heart transplantation were included.

Heart Transplant 40

Heart Transplant Transplant Outcomes Myocardial Infarction 40

Cardiology Update

JANUARY 22, 2024

The Resynchronization–Defibrillation for Ambulatory Heart Failure Trial (RAFT; NCT00251251 ) demonstrated a greater 5-year mortality benefit for patients receiving cardiac-resynchronization therapy (CRT) compared to those receiving implantable cardioverter–defibrillators (ICDs). Secondary outcomes were experienced by 77.7%

Heart Failure 115

Heart Failure Defibrillator Heart Transplant Transplant 115

Frontiers in Cardiovascular Medicine

MARCH 7, 2024

However, information on its efficacy and safety in patients with heart failure remains limited. Case presentation A 43-year-old man with a body mass index of 41 kg/m 2 was admitted to our hospital for acute heart failure due to dilated cardiomyopathy. No adverse events were observed during B-SES.

Heart Failure 124

Heart Failure Obesity Heart Transplant Transplant 124

Journal of Cardiothoracic Surgery

AUGUST 23, 2024

Fulminant myocarditis has been defined as the clinical manifestation of cardiac inflammation with rapid-onset heart failure and cardiogenic shock. We report on the case of a 17-year-old boy with hemodynamic de.

Cardiogenic Shock 52

Cardiogenic Shock Heart Transplant Transplant Heart Failure 52

Circulation

SEPTEMBER 10, 2024

Early identification of kidney dysfunction in patients with advanced heart failure is crucial for timely interventions. Circulation, Ahead of Print. Hemodynamic derangements and maladaptive neurohormonal upregulations contribute to fluctuations in kidney indices and electrolytes that may recover with guideline-directed medical therapy.

Heart Failure 45

Heart Failure Kidney Disease Heart Transplant Transplant 45

Medical Xpress - Cardiology

FEBRUARY 12, 2024

Pediatric heart transplantation has long been hailed as a life-saving intervention for children suffering from end-stage heart failure. While the procedure offers hope, the long-term outcomes for these young patients remain suboptimal due to allograft rejection and graft failure.

Transplant 71

Transplant Pediatrics Heart Transplant Heart Failure 71

DAIC

JUNE 24, 2024

a privately held company dedicated to advancing the treatment of heart failure ( HF ) at the intersection of digital health and medtech, today announced Premarket Approval (PMA) from the U.S milla1cf Mon, 06/24/2024 - 20:21 June 24, 2024 — Endotronix, Inc. ,

Heart Failure 109

Heart Failure Reimbursement Heart Transplant Pulmonary 109

DAIC

FEBRUARY 22, 2024

The inherited heart condition often goes undiagnosed until it advances to heart failure, which is why it’s important to identify those at risk and begin treatment early. heart failure/heart transplant programs that contributed to the study. DCM can be silent for months to years before symptoms begin.

Heart Failure 104

Heart Failure Sudden Cardiac Death Heart Transplant Cardiomyopathy 104

DAIC

MARCH 13, 2024

CMS has reviewed the CardiAMP Heart Failure II Trial and approved the investigational product, related and routine items and services for purposes of Medicare coverage. The CardiAMP Heart Failure II Trial is FDA approved to enroll up to 250 patients at up to 40 clinical centers. said Peter Altman , PhD.,

CMS 111

CMS Heart Failure Reimbursement Quality of Life 111

Frontiers in Cardiovascular Medicine

JANUARY 25, 2024

The implantation of left ventricular assist devices (LVADs) has been increasing, with good long-term results, in parallel with a growing population with advanced heart failure (HF). However, in some European countries, LVADs are still underused, with one of the main issues being the patient's late referral.

Bicuspid/Mitral 69

Bicuspid/Mitral Heart Failure Heart Transplant Transplant 69

DAIC

FEBRUARY 21, 2024

As the only pediatric heart transplant program in Louisiana and the only program in the state to offer advanced mechanical support options for pediatric cardiology patients, Ochsner Children’s Hospital is committed to advocating for additional medical devices to enhance its high-quality care to pediatric patients awaiting transplant.

Pediatrics 105

Pediatrics Hospital Heart Failure Transplant 105

Med Page Today

FEBRUARY 13, 2024

(MedPage Today) -- To more fairly rank candidates for heart transplant, researchers developed the U.S. candidate risk score (US-CRS) and found it to better discriminate risk for people with advanced heart failure than the current six-status system.

Heart Transplant 64

Heart Transplant Transplant Heart Failure Research 64

Circulation: Heart Failure

AUGUST 1, 2024

Circulation: Heart Failure, Ahead of Print.

Heart Transplant 40

Heart Transplant Education Transplant Heart Failure 40

Circulation: Heart Failure

FEBRUARY 1, 2024

Circulation: Heart Failure, Ahead of Print. BACKGROUND:Clinical evaluation of central venous pressure is difficult, depends on experience, and is often inaccurate in patients with chronic advanced heart failure. 0.84]) and confirmed in the validation cohort (receiver operating characteristic, 0.82 [95% CI, 0.73–0.92]).

Heart Failure 40

Heart Failure Ultrasound Heart Transplant Pulmonary 40

Circulation: Heart Failure

MARCH 8, 2024

Circulation: Heart Failure, Ahead of Print. Centers performing at least 1 heart transplant or left ventricular assist device were classified as ATCs. Patient characteristics, outcomes, and procedural volume were compared among 3 cohorts: admissions to non-ATCs, admissions to ATCs, and transfers to ATCs.

Heart Failure 40

Heart Failure Cardiogenic Shock Outcomes Cardiac Arrest 40

Circulation: Heart Failure

FEBRUARY 1, 2024

Circulation: Heart Failure, Ahead of Print. BACKGROUND:In 2018, an algorithm-based allocation system for heart transplantation (HT) was implemented in France. The cumulative incidence of waitlist mortality estimated with competing risk analysis and incidence of transplantation were compared between diagnosis groups.

Heart Failure 40

Heart Failure Congenital Heart Disease Congenital Cardiomyopathy 40

DAIC

DECEMBER 8, 2023

The DRAIN-HF study will evaluate the Aortix percutaneous mechanical circulatory support (pMCS) technology in patients with acute decompensated heart failure (ADHF) who are unresponsive to standard medical therapy. I am excited to be able to include the advanced heart failure patients in the trial," commented Dr. Grafton.

Technology 113

Technology Heart Failure Heart Transplant Transplant 113

European Journal of Heart Failure

OCTOBER 3, 2023

Characteristics of heart failure with improved ejection fraction (HFimpEF) patients and outcome comparison with heart failure with persistently reduced ejection fraction (pHFrEF). CV mortality is the composite endpoint for CV mortality + urgent transplant + left ventricular assist device implantation.

Heart Failure 40

Heart Failure Exercise Laboratory Transplant 40

Circulation: Heart Failure

DECEMBER 11, 2023

Circulation: Heart Failure, Ahead of Print.

Heart Transplant 40

Heart Transplant Transplant Heart Failure Circulation 40

DAIC

APRIL 16, 2024

a commercial-stage medical device company, announced today the availability of additional data, including the publication of results of the post-market phase of the BeAT-HF trial in the European Journal of Heart Failure. The manuscript is available online at the European Journal of Heart Failure website.

Heart Failure 104

Heart Failure Quality of Life Transplant Heart Transplant 104

Heart 2023 Conference

JANUARY 17, 2024

This institute is dedicated to pioneering research, innovation, and the development of clinically effective techniques for addressing various heart conditions. Additionally, it offers comprehensive cardiac screening and preventive care.

Congenital Heart Disease 49

Congenital Heart Disease Coronary Artery Disease Heart Transplant Transplant 49

Open Heart

NOVEMBER 25, 2022

Objective The role of hyperuricaemia as a prognostic maker has been established in chronic heart failure (HF) but limited information on the association between plasma uric acid (UA) levels and central haemodynamic measurements is available. Conclusions Elevated UA is associated with greater haemodynamic impairment in advanced HF.

Heart Failure 52

Heart Failure Outcomes Heart Transplant Artificial Heart 52

CardiacWire

AUGUST 21, 2024

Johnson & Johnson expanded deeper into heart failure and interventional cardiology, acquiring interatrial shunt-maker V-Wave for $600M upfront and up to $1.7B These improvements would allow the Ventura IAS to address the notable HFrEF treatment gap between GDMT and far more invasive therapies like LVAD and heart transplantation.

Heart Transplant 64

Heart Transplant Heart Failure Interventional Cardiology Transplant 64

Circulation: Heart Failure

NOVEMBER 6, 2023

Circulation: Heart Failure, Ahead of Print.

Heart Transplant 40

Heart Transplant Transplant Heart Failure Circulation 40

DAIC

APRIL 30, 2024

Study shows that cardiac spheroids, derived from human induced pluripotent stem cells, can be easily transported and injected into damaged areas of the heart to promote its regeneration and recovery of function. Heart attacks typically kill millions of cardiac muscle cells, leaving the heart in a weakened state.

Transplant 105

Transplant Heart Transplant Myocardial Infarction Heart Attack 105

European Journal of Heart Failure

DECEMBER 13, 2023

For the global rank score all participants were ranked across three hierarchical groups: Tier 1 = time to death or urgent heart transplantation or implantation of a ventricular assist device; Tier 2 = time to non-fatal HF requiring i.v.

Heart Failure 40

Heart Failure COVID-19 Hospital Heart Transplant 40

DAIC

MAY 15, 2024

The HeartMate 3 is used for both short- and long-term support in pediatric and adult patients with severe left ventricular heart failure. It can be used while waiting for a heart transplant, to help the heart recover, or as a permanent solution when a transplant isn't an option.

Transplant 105

Transplant Heart Failure Heart Transplant Pediatrics 105

Heart BMJ

NOVEMBER 27, 2023

There were great advances in the treatment of heart failure (HF) over the past decades, characterised by the inclusion of ARNI and SGLT2 inhibitors in the latest guidelines. 1 The increasing repertoire of treatments makes it even more important to select those patients who will benefit the most from these therapies.

Cardiomyopathy 40

Cardiomyopathy Heart Transplant Transplant Heart Failure 40

European Journal of Heart Failure

NOVEMBER 9, 2023

Abstract Aim Cardiac resynchronization therapy (CRT) is a cornerstone in the management of chronic heart failure in patients with a broad or paced QRS. The primary composite endpoint included all-cause mortality, heart transplantation, or ventricular assist device implantation. ml/min/1.73 m ml/min/1.73 m

Outcomes 40

Outcomes Heart Failure Heart Transplant Transplant 40

European Journal of Heart Failure

NOVEMBER 7, 2023

AV, atrioventricular; BNP, brain natriuretic peptide; CMR, cardiac magnetic resonance imaging; FDG-PET, fluorodeoxyglucose positron emission tomography; HF, heart failure; LVEF, left ventricular ejection fraction; SCD, sudden cardiac death; SUVmax, maximum standardized uptake value; VT, ventricular tachycardia.

Sudden Cardiac Death 40

Sudden Cardiac Death Outcomes Heart Transplant Heart Failure 40

DAIC

APRIL 15, 2024

The HeartMate II and 3 are used for both short- and long-term support in adult patients with severe left ventricular heart failure. It can be used while waiting for a heart transplant, to help the heart recover, or as a permanent solution when a transplant isn't an option.

Transplant 105

Transplant Heart Transplant Pediatrics Heart Failure 105

All About Cardiovascular System and Disorders

FEBRUARY 24, 2024

Heart failure, heart transplantation and death by cardiac causes were more often seen in individuals with biventricular phenotype compared to isolated left or right ventricular phenotype.

Cardiomyopathy 52

Cardiomyopathy Chest Pain Heart Transplant Myocardial Infarction 52

European Journal of Heart Failure

DECEMBER 13, 2023

CV, cardiovascular; HT, heart transplantation; ICU, intensive care unit; LVAD, left ventricular assist device. The primary endpoint was the rate of weaning from VA-ECMO during index admission. The early LV unloading strategy did not increase the weaning rate from VA-ECMO compared with the conventional approach.

Aortic valve 75

Aortic valve Cardiac Arrest Heart Transplant Pulmonary 75

Circulation

JANUARY 18, 2024

Six hours of exposure to VA-ECMO also decreased left ventricular levels of cardiolipin and tafazzin in healthy swine compared with sham controls.

Myocardial Infarction 45

Myocardial Infarction Heart Transplant Ischemia Transplant 45

Circulation: Genomic and Precision Medicine

SEPTEMBER 28, 2023

Background:Many cardiovascular disorders propel the development of advanced heart failure that necessitates cardiac transplantation. Damaging gene variants are significantly more frequent among transplant compared with patients with ambulatory cardiomyopathy. of patients with unexplained end-stage cardiomyopathy.

Heart Transplant 40

Heart Transplant Transplant Cardiomyopathy Pediatrics 40

DAIC

FEBRUARY 13, 2024

Pictured Left to Right: Members and students of the McGill Gene Editing Laboratory at The Texas Heart Institute in Houston, Texas: Fansen Meng, PhD, Xiao Li, PhD, James Martin, MD, PhD, Rich Li, PhD (back), Maggie Lim (undergraduate student at Rice University front), Yuka Morikawa, PhD, Ann Bromley.

Transplant 111

Transplant Pediatrics Heart Transplant Research 111